APP and Alzheimer disease: Although many studies have highlighted the neurotoxicity of Aβ as a possible cause for AD, accumulating evidence points to endocytosis, trafficking and intracellular sorting of Amyloid Precursor Protein (APP) as potential targets to address the pathology in humans [1,2,3,4,5].